JP2006160699A - New isoprenoid quinone - Google Patents

New isoprenoid quinone Download PDF

Info

Publication number
JP2006160699A
JP2006160699A JP2004357556A JP2004357556A JP2006160699A JP 2006160699 A JP2006160699 A JP 2006160699A JP 2004357556 A JP2004357556 A JP 2004357556A JP 2004357556 A JP2004357556 A JP 2004357556A JP 2006160699 A JP2006160699 A JP 2006160699A
Authority
JP
Japan
Prior art keywords
compound
culture
quinone
compound according
microorganisms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004357556A
Other languages
Japanese (ja)
Inventor
Kyoko Adachi
恭子 足立
Manabu Ho
学 彭
Hiroo Kasai
宏朗 笠井
Norihiko Misawa
典彦 三沢
Matsuko Katsuta
麻津子 勝田
Yoshiichi Shizuri
芳一 志津里
Satoshi Matsuda
諭 松田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Marine Biotechnology Institute Co Ltd
Original Assignee
Marine Biotechnology Institute Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marine Biotechnology Institute Co Ltd filed Critical Marine Biotechnology Institute Co Ltd
Priority to JP2004357556A priority Critical patent/JP2006160699A/en
Publication of JP2006160699A publication Critical patent/JP2006160699A/en
Pending legal-status Critical Current

Links

Abstract

<P>PROBLEM TO BE SOLVED: To provide new indicator compounds for the chemical classification of Nocardia microorganisms, to provide a method for producing the compounds using such microorganisms, and to provide a chemical classification method of the Nocardia microorganisms. <P>SOLUTION: The compounds are represented by formula(I) and formula(II) respectively. The method for producing the compounds using the microorganisms is provided. The method for classifying the microorganisms with these compounds as indicators is also provided. <P>COPYRIGHT: (C)2006,JPO&NCIPI

Description

本発明は、化学分類の指標として有用な新規化合物、および微生物を用いたその製造法、並びにそれら化合物を指標とした微生物の分類法に関する。   The present invention relates to a novel compound useful as an indicator for chemical classification, a method for producing the same using microorganisms, and a method for classifying microorganisms using these compounds as indicators.

従来、細菌の化学分類の重要な指標として、一般的にほとんどの細菌に含まれている菌体内脂肪酸組成とイソプレノイドキノン(以下単に「キノン」と称する)組成が主に使用されてきた(非特許文献1)。キノンは、細菌の細胞膜に含まれる呼吸鎖や光合成電子伝達鎖の必須成分である。構造的にはナフトキノン型およびベンゾキノン型の2つに大別され、それぞれメナキノン(2-Methyl-3-polyprenyl-1,4-naphthoquinone)とユビキノン(2-methyl-1,3-methoxy-3-polyprenyl-1,4-benzquinone)に代表される。両キノングループにはいくつかの生合成上の誘導体が存在する。化学分類上有効な指標となりうるのは、キノン骨格の構造的差異の他、イソプレノイド側鎖の長さと水素飽和度、修飾基の有無等である。このような分類群に特有なキノンの構造的差異は遺伝的に安定しており、培養環境条件の影響による優占キノン種の変動もほとんどない。   Conventionally, intracellular fatty acid composition and isoprenoid quinone (hereinafter simply referred to as “quinone”) composition, which are generally contained in most bacteria, have been mainly used as important indicators of chemical classification of bacteria (non-patented). Reference 1). Quinones are essential components of respiratory chains and photosynthetic electron transport chains contained in bacterial cell membranes. Structurally, it is roughly divided into naphthoquinone type and benzoquinone type, and menaquinone (2-Methyl-3-polyprenyl-1,4-naphthoquinone) and ubiquinone (2-methyl-1,3-methoxy-3-polyprenyl), respectively. -1,4-benzquinone). There are several biosynthetic derivatives in both quinone groups. In addition to structural differences of the quinone skeleton, the isoprenoid side chain length and hydrogen saturation, the presence / absence of a modifying group, and the like can be useful indicators for chemical classification. The structural differences of quinones peculiar to such taxonomic groups are genetically stable, and there is almost no change in dominant quinone species due to the influence of culture environment conditions.

グラム陽性菌のノカルディア科に属する微生物は、炭化水素分解能を有しているものは活性汚泥中で重要な役割を果たしていたり(特許文献1、2)、魚の感染症の原因となる場合もあり、菌の分類学的同定が必要なことが多い。今までの研究で、ノカルディア属の微生物の優占キノン種は、メナキノンのイソプレノイド側鎖の末端がシクロヘキセン環になった珍しいものであることが明らかになっている(非特許文献2、3)。しかしながら、調べられた微生物はノカルディア科のなかの限られた属でしかないので、それ以外の属の新規優占キノン種の解明と、その新規キノン化合物の提供が望まれている。   Microorganisms belonging to the Nocardia family of Gram-positive bacteria that have hydrocarbon degradability play an important role in activated sludge (Patent Documents 1 and 2), and may cause fish infections Often, taxonomic identification of fungi is necessary. Research so far has revealed that the dominant quinone species of Nocardia microorganisms are unusual in which the end of the isoprenoid side chain of menaquinone is a cyclohexene ring (Non-patent Documents 2 and 3). . However, since the microorganisms examined are only a limited genus in the Nocardiaceae family, it is desired to elucidate new dominant quinone species of other genera and provide the new quinone compound.

Goodfellow, M. and O’Donnell, A. G. (eds.) (1994) Chemical methods in prokaryotic systematics. John Wiley & Son, Chichester.Goodfellow, M. and O’Donnell, A. G. (eds.) (1994) Chemical methods in prokaryotic systematics. John Wiley & Son, Chichester. Howarth, O. W., Grund, E., and Kroppenstedt, R. M. Biochem. Res. Commun., 140, 916-923(1986).Howarth, O. W., Grund, E., and Kroppenstedt, R. M. Biochem. Res. Commun., 140, 916-923 (1986). Collins, M. D., Howarth, O. W., Grund, E., and Kroppenstedt, R. M., FEBS Microbial. Lett., 41, 35-39(1987).Collins, M. D., Howarth, O. W., Grund, E., and Kroppenstedt, R. M., FEBS Microbial. Lett., 41, 35-39 (1987). 特開2002−101872号公報JP 2002-101872 A 特開2004−222526号公報JP 2004-222526 A

上記事情に鑑み、本発明は、新規な優占キノン種をノカルディア科の新規微生物から検索し、その新規 キノン化合物およびその製造法、ならびに新規キノン化合物を指標とした化学分類法を提供することを目的とする。   In view of the above circumstances, the present invention provides a novel quinone compound, a production method thereof, and a chemical classification method using the novel quinone compound as an index, by searching for a new dominant quinone species from a novel microorganism of the Nocardia family. With the goal.

本発明者らは、上記課題を解決するために鋭意検討を重ねた結果、自然界から新たに分離されたノカルディア科の新規微生物の生産する優占キノン種が、新規キノン化合物であることを見出し、本発明を完成するに至った。   As a result of intensive studies in order to solve the above problems, the present inventors have found that the dominant quinone species produced by a novel microorganism of the Nocardiaceae newly isolated from the natural world is a novel quinone compound. The present invention has been completed.

すなわち、本発明は、以下の(1)〜(6)を提供するものである。   That is, the present invention provides the following (1) to (6).

(1)下記式(I)で表される化合物。 (1) A compound represented by the following formula (I).

Figure 2006160699
Figure 2006160699

(2)下記式(II)で表される化合物。 (2) A compound represented by the following formula (II).

Figure 2006160699
Figure 2006160699

(3)ノカルディア科に属し、(1)記載の化合物と(2)記載の化合物とを生産することを特徴とする微生物。 (3) A microorganism belonging to the family Nocardia and producing the compound described in (1) and the compound described in (2).

(4)配列番号1記載の塩基配列と97%以上の相同性を示す塩基配列で表される16S rRNA遺伝子を持つ(3)記載の微生物。 (4) The microorganism according to (3) having a 16S rRNA gene represented by a base sequence having 97% or more homology with the base sequence described in SEQ ID NO: 1.

(5)(1)記載の化合物又は(2)記載の化合物を生産する能力を有するノカルディア科微生物を培地に培養し、培養物中に(1)記載の化合物又は(2)記載の化合物を生成蓄積させ、該培養物から(1)記載の化合物又は(2)記載の化合物を採取することを特徴とする(1)記載の化合物又は(2)記載の化合物の製造法。 (5) The compound of (1) or the Nocardiaceae microorganism having the ability to produce the compound of (2) is cultured in a medium, and the compound of (1) or the compound of (2) is contained in the culture. A method for producing the compound according to (1) or the compound according to (2), wherein the compound according to (1) or the compound according to (2) is collected from the culture and collected.

(6)(1)記載の化合物又は(2)記載の化合物を指標とするノカルディア科に属する微生物の分類法。 (6) A method for classifying a microorganism belonging to the Nocardia family using the compound described in (1) or the compound described in (2) as an index.

本発明は、微生物の新規な化学分類指標物質及び該物質の微生物を用いた製造法を提供する。本発明の化合物は、ノカルディア科微生物の分類の指標として有用である。   The present invention provides a novel chemical classification indicator substance for microorganisms and a method for producing the substance using microorganisms. The compounds of the present invention are useful as an indicator of the classification of Nocardiaceae microorganisms.

以下に本発明を詳細に説明する。   The present invention is described in detail below.

本発明の化合物は、最初にノカルディア科新規(新属新種)微生物 Hou_blue株から単離・精製された化合物である。本発明の化合物の性質及びその製造方法について以下に詳述する。   The compound of the present invention is a compound that was first isolated and purified from Hou_blue strain, a novel (new genus and new species) microorganism of the Nocardia family. The properties of the compound of the present invention and the production method thereof will be described in detail below.

1.本発明の化合物の性質
本発明の化合物は、下記式(I)ならびに(II)により表される化合物である。
1. Properties of the Compound of the Present Invention The compound of the present invention is a compound represented by the following formulas (I) and (II).

Figure 2006160699
Figure 2006160699

Figure 2006160699
Figure 2006160699

上記式(I)で表される化合物の理化学的性質は以下のとおりである:
(1)物質の色 :黄色
(2)分子量 :720
(3)分子式 :C51H76O2
(4)質量分析 :高分解能FABMS(高速中性粒子衝突イオン化質量分析)
実測値 720.5858 [M]
計算値 720.5842(C51H76O2
(5)紫外線吸収スペクトル(メタノール中) λmax(logε) 248nm (4.07)、262nm (3.99)、328nm (3.29)
(6)H NMR(重クロロホルム中で測定、750MHz)
δppm 0.81(3H, d, J=6.6Hz), 0.82(3H, s), 0.83(3H, d, J=6.6Hz), 0.90(3H, s), 0.96-1.16(5H, m), 1.17-1.40(13H, m), 1.44(1H, m), 1.52(3H, m), 1.57(3H, s), 1.58(6H, s), 1.65(2H, m), 1.71(1H, m), 1.76(3H, s), 1.92(4H, m), 1.96(6H, m), 2.05(5H, m), 2.18(3H, s), 3.36(2H, d, 6.9Hz), 4.52 (1H, s), 4.74 (1H, s), 5.00(1H, t, 6.8Hz), 5.10(3H, m), 7.68(1H, m), 8.07(1H, m)
(7)13C NMR(重クロロホルム中で測定、125MHz)
δppm 12.77, 16.05, 16.11, 16.19, 16.40, 16.73, 19.78, 23.84, 24.50, 24.90, 25.40, 25.57, 26.09, 23.36, 26.76, 26.80, 28.53, 32.53, 32.63, 32.72, 34.95, 36.46, 36.74, 37.19, 37.36, 37.46, 38.29, 39.83, 39.85, 40.09, 53.65, 108.74, 108.77, 123.95, 124.24, 124.89, 126.12, 126.24, 132.11, 132.16, 133.17, 133.22, 134.49, 134.81, 135.40, 137.88, 143.25, 146.15, 149.30, 184.38, 185.32
(8)溶解性 :クロロホルム、アセトン、メタノールに可溶。
The physicochemical properties of the compound represented by the above formula (I) are as follows:
(1) Material color: Yellow (2) Molecular weight: 720
(3) Molecular formula: C 51 H 76 O 2
(4) Mass spectrometry: High resolution FABMS (fast neutral particle impact ionization mass spectrometry)
Actual value 720.5858 [M] +
Calculated value 720.5842 (C 51 H 76 O 2 )
(5) UV absorption spectrum (in methanol) λmax (logε) 248nm (4.07), 262nm (3.99), 328nm (3.29)
(6) 1 H NMR (measured in deuterated chloroform, 750 MHz)
δppm 0.81 (3H, d, J = 6.6Hz), 0.82 (3H, s), 0.83 (3H, d, J = 6.6Hz), 0.90 (3H, s), 0.96-1.16 (5H, m), 1.17- 1.40 (13H, m), 1.44 (1H, m), 1.52 (3H, m), 1.57 (3H, s), 1.58 (6H, s), 1.65 (2H, m), 1.71 (1H, m), 1.76 (3H, s), 1.92 (4H, m), 1.96 (6H, m), 2.05 (5H, m), 2.18 (3H, s), 3.36 (2H, d, 6.9Hz), 4.52 (1H, s) , 4.74 (1H, s), 5.00 (1H, t, 6.8Hz), 5.10 (3H, m), 7.68 (1H, m), 8.07 (1H, m)
(7) 13 C NMR (measured in deuterated chloroform, 125 MHz)
δppm 12.77, 16.05, 16.11, 16.19, 16.40, 16.73, 19.78, 23.84, 24.50, 24.90, 25.40, 25.57, 26.09, 23.36, 26.76, 26.80, 28.53, 32.53, 32.63, 32.72, 34.95, 36.46, 36.74, 37.19, 37.36 , 37.46, 38.29, 39.83, 39.85, 40.09, 53.65, 108.74, 108.77, 123.95, 124.24, 124.89, 126.12, 126.24, 132.11, 132.16, 133.17, 133.22, 134.49, 134.81, 135.40, 137.88, 143.25, 146.15, 143.149 , 185.32
(8) Solubility: Soluble in chloroform, acetone and methanol.

上記式(II)で表される化合物の理化学的性質は以下のとおりである:
(1)物質の色 :黄色
(2)分子量 :734
(3)分子式 :C52H78O2
(4)質量分析 :高分解能FABMS
実測値 734.5914 [M]
計算値 734.6002(C52H78O2
(5)紫外線吸収スペクトル(メタノール中) λmax(logε) 248nm (4.08)、262nm (4.00)、329nm (3.29)
(6)H NMR(重クロロホルム中で測定、750MHz)
δppm 0.80(3H, d, J=6.6Hz), 0.81(3H, s), 0.82(3H, s), 0.83(3H, d, J=6.6Hz), 0.90(3H, s), 1.00 (3H, s), 0.96-1.16(6H, m), 1.17-1.40(14H, m), 1.40-1.52(5H, m), 1.56(6H, s), 1.57(1H, m), 1.65 (2H, m), 1.76 (3H, s), 1.88-1.94 (6H, m), 1.96-2.06(4H, m), 2.10-2.22 (2H, m), 2.18(3H, s), 3.36(2H, d, 6.9Hz), 4.55(1H, s), 4.75(1H, s), 5.00(1H, t, 6.8Hz), 5.06 (1H, t, 6.8Hz), 7.68(1H, m), 8.07(1H, m)
(7)13C NMR(重クロロホルム中で測定、125MHz)
δppm 12.77, 16.34, 16.40, 18.49 , 19.74, 19.78, 23.82, 24.50, 24.59, 25.41, 25.41, 25.59, 26.09, 26.48, 27.57, 28.52, 29.74, 30.96, 32.58, 32.58, 32.73, 34.78, 34.97, 36.35, 36.74, 37.01, 37.23, 37.37, 37.47, 39.01, 40.09, 41.40, 51.90, 54.67, 108.72, 118.77, 124.08, 126.12, 126.24, 127.24, 132.11, 132.16, 133.18, 133.23, 135.65, 137.89, 140.04, 143.25, 146.15, 149.49, 184.38, 185.32
(8)溶解性 :クロロホルム、アセトン、メタノールに可溶。
The physicochemical properties of the compound represented by the above formula (II) are as follows:
(1) Material color: Yellow (2) Molecular weight: 734
(3) Molecular formula: C 52 H 78 O 2
(4) Mass spectrometry: High resolution FABMS
Actual value 734.5914 [M] +
Calculated value 734.6002 (C 52 H 78 O 2 )
(5) UV absorption spectrum (in methanol) λmax (logε) 248nm (4.08), 262nm (4.00), 329nm (3.29)
(6) 1 H NMR (measured in deuterated chloroform, 750 MHz)
δppm 0.80 (3H, d, J = 6.6Hz), 0.81 (3H, s), 0.82 (3H, s), 0.83 (3H, d, J = 6.6Hz), 0.90 (3H, s), 1.00 (3H, s), 0.96-1.16 (6H, m), 1.17-1.40 (14H, m), 1.40-1.52 (5H, m), 1.56 (6H, s), 1.57 (1H, m), 1.65 (2H, m) , 1.76 (3H, s), 1.88-1.94 (6H, m), 1.96-2.06 (4H, m), 2.10-2.22 (2H, m), 2.18 (3H, s), 3.36 (2H, d, 6.9Hz ), 4.55 (1H, s), 4.75 (1H, s), 5.00 (1H, t, 6.8Hz), 5.06 (1H, t, 6.8Hz), 7.68 (1H, m), 8.07 (1H, m)
(7) 13 C NMR (measured in deuterated chloroform, 125 MHz)
δppm 12.77, 16.34, 16.40, 18.49, 19.74, 19.78, 23.82, 24.50, 24.59, 25.41, 25.41, 25.59, 26.09, 26.48, 27.57, 28.52, 29.74, 30.96, 32.58, 32.58, 32.73, 34.78, 34.97, 36.35, 36.74 , 37.01, 37.23, 37.37, 37.47, 39.01, 40.09, 41.40, 51.90, 54.67, 108.72, 118.77, 124.08, 126.12, 126.24, 127.24, 132.11, 132.16, 133.18, 133.23, 135.65, 137.89, 140.04, 143.25, 146. , 184.38, 185.32
(8) Solubility: Soluble in chloroform, acetone and methanol.

2.本発明の化合物の製造
2.1.式(I)又は(II)の化合物の製造
本発明の式(I)又は(II)の化合物は、微生物を培地に培養し、培養物中に該化合物を生成蓄積させ、該培養物から該化合物を採取することにより製造することができる。
2. Production of compounds of the invention 2.1. Production of Compound of Formula (I) or (II) The compound of formula (I) or (II) of the present invention is obtained by culturing a microorganism in a medium, producing and accumulating the compound in a culture, and It can be produced by collecting the compound.

(1)微生物
本発明の製造方法において用いることのできる微生物としては、ノカルディア科に属し、かつ上記式(I)又は(II)で表される化合物を生産することが可能な微生物であれば特に限定されない。そのような微生物としては、例えば、ノカルディア科Hou_blue株を挙げることができる。ノカルディア科Hou_blue株は自然界から新たに単離した株であり、細菌学的性質については以下の通りである。
(1) Microorganism The microorganism that can be used in the production method of the present invention is a microorganism that belongs to the Nocardia family and can produce the compound represented by the above formula (I) or (II). There is no particular limitation. Examples of such microorganisms include Nocardiaaceae Hou_blue strain. The Nocardiaceae Hou_blue strain is a newly isolated strain from nature, and its bacteriological properties are as follows.

a.形態的性質
1) 細胞の形及び大きさ :球菌、0.86×0.86μm
2) 運動性の有無 :無し
b.培養的性質
1) ISP培地 No.2 平板培養 :灰緑色のコロニー形成
2) ISP培地 No.4 平板培養 :生育しない
3) ISP培地 No.5 平板培養 :生育しない
4) ISP培地 No.6 平板培養 :灰緑色のコロニー形成
5) ISP培地 No.7 平板培養 :生育しない
6) 1/10 Tryptic Soy 寒天平板培養 :灰緑色のコロニー形成
c.生理学的性質
1) 生育温度範囲 :4−37度
2) メラニン様色素の生成 :生成しない
3) アルカリホスファターゼ活性 :陰性
4) エステラーゼ(C4)活性 :陽性
5) エステラーゼリパーゼ(C8)活性 :陽性
6) エステラーゼ(C4)活性 :陽性
7) ロイシン アリルアミダーゼ活性:陽性
8) バリン アリルアミダーゼ活性 :陰性
9) シスチン アリルアミダーゼ活性:陰性
10) トリプシン活性 :陰性
11) キモトリプシン活性 :陰性
12) 酸性フォスファターゼ活性 :陰性
13) ナフトール-AS-BI-ホスホハイドロラーゼ活性:陽性
14) α-ガラクトシダーゼ活性 :陰性
15) β-ガラクトシターゼ活性 :陰性
16) β-グルクロニダーゼ活性 :陰性
17) α-グルコシダーゼ活性 :陰性
18) β-グルコシダーゼ活性 :陰性
19) α-マンノシダーゼ活性 :陰性
20) α-フコシダーゼ活性 :陰性
21)炭素源の利用性
L-アラビノース :−
D-フルクトース :+
D-グルコース :+
イノシトール :−
D-マンニトール :−
L-ラムノース :−
ラフィノース :−
シュークロース :−
D-キシロース :−
酪酸 :+
ヘキサデカン :+
基礎培地としてW培地(組成下記)を使用した。
a. Morphological properties
1) Cell shape and size: Cocci, 0.86 x 0.86μm
2) Presence or absence of mobility: None
b. Culture properties
1) ISP medium No.2 Plate culture: Grayish green colony formation
2) ISP medium No.4 Plate culture: No growth
3) ISP medium No.5 Plate culture: No growth
4) ISP medium No.6 Plate culture: Grayish green colony formation
5) ISP medium No.7 Plate culture: No growth
6) 1/10 Tryptic Soy Agar plate culture: Gray green colony formation
c. Physiological properties
1) Growth temperature range: 4-37 degrees
2) Formation of melanin-like pigment: Not generated
3) Alkaline phosphatase activity: Negative
4) Esterase (C4) activity: Positive
5) Esterase lipase (C8) activity: positive
6) Esterase (C4) activity: Positive
7) Leucine allylamidase activity: positive
8) Valine allylamidase activity: negative
9) Cystine allylamidase activity: negative
10) Trypsin activity: negative
11) Chymotrypsin activity: Negative
12) Acid phosphatase activity: Negative
13) Naphthol-AS-BI-phosphohydrolase activity: positive
14) α-Galactosidase activity: Negative
15) β-galactosidase activity: negative
16) β-glucuronidase activity: negative
17) α-Glucosidase activity: Negative
18) β-glucosidase activity: negative
19) α-Mannosidase activity: Negative
20) α-fucosidase activity: negative
21) Use of carbon sources
L-arabinose : −
D-fructose: +
D-glucose: +
Inositol:-
D-mannitol:-
L-rhamnose:-
Raffinose:-
Sucrose:-
D-xylose:-
Butyric acid: +
Hexadecane: +
W medium (composition below) was used as the basal medium.

Figure 2006160699
Figure 2006160699

ゲノムDNAのG+C含量 63.7 mol% (HPLC法で測定)
ノカルディア科Hou_blue株の16S rRNA遺伝子の塩基配列は、配列番号1に示すとおりである。Gen BankのデータベースならびにBLAST programを用い、16S rRNA遺伝子の塩基配列の相同性で近い微生物種を探索ところ、最も近いノカルディア科ロドコッカス属の既知株AJ002749.1 Rhodococcus sp. 16S rRNA gene, strain GW-86a と94%の相同性しか無く、本発明の微生物はノカルディア科の新属新種の微生物と判明した。
G + C content of genomic DNA 63.7 mol% (measured by HPLC method)
The base sequence of 16S rRNA gene of Nocardiaaceae Hou_blue strain is as shown in SEQ ID NO: 1. Using the GenBank database and BLAST program, we searched for the closest microbial species based on the homology of the base sequence of the 16S rRNA gene, and found the closest known strain of Rhodococcus sp. 16S rRNA gene, strain GW- There was only 94% homology with 86a, and the microorganism of the present invention was found to be a microorganism of a new genus and new species of the Nocardia family.

なお、ノカルディア科Hou_blue株は、独立行政法人 製品評価技術基盤機構 バイオテクノロジー本部(千葉県木更津市かずさ鎌足2-5-8)に、平成16年6月8日に、寄託番号NITE P-3として寄託されている。   In addition, Nocardia Department Hou_blue shares were registered with the National Institute of Technology and Evaluation Biotechnology Headquarters (2-5-8 Kazusa-Kamashita, Kisarazu City, Chiba Prefecture) on June 8, 2004 with the deposit number NITE P- Deposited as 3.

ノカルディア科Hou_blue株の代わりに、該菌株に由来する変異株、あるいは該菌株の類似菌株を挙げることができる。ここでいう「変異株」や「類似菌株」としては、例えば、ノカルディア科Hou_blue株の16S rRNA遺伝子(配列番号1)と高い相同性を示す16S rRNA遺伝子を持つ菌株を挙げることができる。「高い相同性」とは、通常、97%以上相同であることを意味し、好ましくは、98%以上相同であることを意味し、最も好ましくは100%相同あることを意味する。   Instead of the Nocardia family Hou_blue strain, a mutant strain derived from the strain or a similar strain of the strain can be mentioned. Examples of the “mutant strain” and “similar strain” herein include a strain having a 16S rRNA gene having high homology with the 16S rRNA gene (SEQ ID NO: 1) of the Nocardia department Hou_blue strain. “High homology” usually means 97% or more homology, preferably 98% or more homology, and most preferably 100% homology.

(2)微生物の培養
本発明における微生物の培養は、通常の微生物の培養方法が用いられる。培地としては、資化可能な炭素源、窒素源、無機物及び必要な生育・生産促進物質を適宜含有する培地であれば、合成培地又は天然培地のいずれでも使用可能である。炭素源としては、グルコース、澱粉、デキストリン、マンノース、フラクトース、糖蜜などを単独又は組み合わせて用いられる。さらに、必要に応じて炭化水素、アルコール類、有機酸、アミノ酸(トリプトファン等)なども用いられる。窒素源としては塩化アンモニウム、硫酸アンモニウム、硝酸アンモニウム、硝酸ナトリウム、尿素、ペプトン、肉エキス、酵母エキス、乾燥酵母、コーン・スチープ・リカー、大豆粉、綿実かす、カザミノ酸などが単独又は組み合わせて用いられる。そのほか、必要に応じて食塩、塩化カリウム、硫酸マグネシウム、炭酸カルシウム、リン酸二水素カリウム、リン酸水素二カリウム、硫酸第一鉄、塩化カルシウム、硫酸マンガン、硫酸亜鉛などの無機塩類を加える。さらに使用する微生物の生育や本発明の化合物の生産を促進する微量成分を適当に添加することができ、そのような成分は当業者であれば適当なものを選択することができる。
(2) Microbial culture In the present invention, a normal microorganism culture method is used for the culture of the microorganism. As the medium, any of a synthetic medium or a natural medium can be used as long as it contains an assimilated carbon source, nitrogen source, inorganic substance, and necessary growth / production promoting substances as appropriate. As the carbon source, glucose, starch, dextrin, mannose, fructose, molasses and the like are used alone or in combination. Furthermore, hydrocarbons, alcohols, organic acids, amino acids (such as tryptophan) and the like are used as necessary. As the nitrogen source, ammonium chloride, ammonium sulfate, ammonium nitrate, sodium nitrate, urea, peptone, meat extract, yeast extract, dry yeast, corn steep liquor, soybean flour, cottonseed meal, casamino acid, etc. are used alone or in combination. . In addition, inorganic salts such as sodium chloride, potassium chloride, magnesium sulfate, calcium carbonate, potassium dihydrogen phosphate, dipotassium hydrogen phosphate, ferrous sulfate, calcium chloride, manganese sulfate, and zinc sulfate are added as necessary. Furthermore, trace components that promote the growth of the microorganisms to be used and the production of the compounds of the present invention can be appropriately added, and such components can be appropriately selected by those skilled in the art.

培養法としては、液体培養が適しているが、これに限定されるものではない。培養温度は、20〜30℃が適当であり、培養中の培地のpHは7〜9に維持することが望ましく、震盪速度が30〜120rpmで回転又は往復震盪培養することが望ましい。液体培養で通常10〜14日間培養を行うと、目的化合物が菌体中に生成蓄積される。培養物中の生成量が最大に達した時に培養を停止する。   As a culture method, liquid culture is suitable, but is not limited thereto. The culture temperature is suitably 20-30 ° C., the pH of the medium during culture is desirably maintained at 7-9, and it is desirable to carry out rotation or reciprocal shaking culture at a shaking speed of 30-120 rpm. When culturing is usually carried out for 10 to 14 days in liquid culture, the target compound is produced and accumulated in the cells. The culture is stopped when the production amount in the culture reaches the maximum.

(3)化合物の単離・精製
培養菌体から本発明の化合物を単離・精製するには、微生物代謝生産物をその培養物から単離・精製するために常用される方法に従って行われる。例えば培養物を濾過や遠心分離により培養瀘液と菌体に分け、菌体を凍結乾燥後クロロホルム/メタノール(2:1)混合溶媒などで抽出する。ついで、菌体抽出液を濃縮し、カラムクロマトグラフィー、HPLCなどにより精製を行い、本発明の化合物を得る。得られた化合物は、NMR解析などの通常の化学的手法により、上記「1.本発明の化合物の性質」に記載した性質を示すか否かを調べることにより、本発明の化合物であることを確認することができる。
(3) Isolation / Purification of Compound Isolation / purification of the compound of the present invention from cultured cells is carried out according to a method commonly used for isolating / purifying a microbial metabolic product from the culture. For example, the culture is separated into culture broth and cells by filtration or centrifugation, and the cells are freeze-dried and extracted with a chloroform / methanol (2: 1) mixed solvent or the like. Next, the bacterial cell extract is concentrated and purified by column chromatography, HPLC or the like to obtain the compound of the present invention. The obtained compound is determined to be the compound of the present invention by examining whether or not it exhibits the properties described in “1. Properties of the compound of the present invention” by an ordinary chemical method such as NMR analysis. Can be confirmed.

なお、培養、精製操作中の本発明の化合物の動向は、フォトダイオードアレイ検出器(PDA)付きHPLCならびHLPC/APCI-MSにより、紫外線吸収と質量分析値を指標として追跡することができる。   The trend of the compound of the present invention during the culturing and purification operations can be traced by HPLC with a photodiode array detector (PDA) and HLPC / APCI-MS using ultraviolet absorption and mass spectrometry values as indicators.

3.本発明の化合物の用途
本発明の化合物は、下記のようにしてノカルディア科微生物の分類の指標として利用することができる。
3. Use of the Compound of the Present Invention The compound of the present invention can be used as an index for classification of Nocardiaceae microorganisms as follows.

(1)菌体中のイソプレノイドキノンの組成分析
凍結乾燥菌体(10〜100 mg)をクロロホルム/メタノール(2:1)混合溶媒約5mLで溶解後、遠心分離により上澄み液を分離する。それを、濃縮乾固し、残査を5〜10μLのアセトンに溶解し、HPLC/PDA/APCI-MS/MS分析の試料とする。供した試料中のキノンについて、HPLCにおける保持時間、PDAによる紫外線吸収スペクトルおよびMS/MSパターンを、既知各種キノン類ならびに本発明の化合物の保持時間およびパターンと比較してキノン分子種の同定を行う。同定されたキノン類について、HPLCにおけるピーク面積の比から組成比を算出し、化学分類のためのデータとする。
(1) Compositional analysis of isoprenoid quinone in cells After lyophilized cells (10-100 mg) are dissolved in about 5 mL of a chloroform / methanol (2: 1) mixed solvent, the supernatant is separated by centrifugation. It is concentrated to dryness, and the residue is dissolved in 5 to 10 μL of acetone and used as a sample for HPLC / PDA / APCI-MS / MS analysis. The quinone molecular species is identified by comparing the retention time in HPLC, ultraviolet absorption spectrum by PDA, and MS / MS pattern with the retention times and patterns of known quinones and the compounds of the present invention for the quinones in the samples provided. . For the identified quinones, the composition ratio is calculated from the ratio of peak areas in HPLC and used as data for chemical classification.

(2)キノンプロファイルによる活性汚泥中の細菌の群集解析
汚泥懸濁液にクロロホルム/メタノール(2:1)混合溶媒を加えホモジナイズあるいは超音波処理をする。遠心分離後上層の水層を捨て、中間層ならびに下層(クロロホルム層)をろ紙でろ過する。それを、濃縮乾固し、さらにヘキサン-水(1:1)で溶解後、ヘキサン層を分離する。ヘキサン層を濃縮乾固し、少量のアセトンに溶解してHPLC/PDA/APCI-MS/MS分析の試料とする。上記(1)菌体中のイソプレノイドキノンの組成分析と同様にして組成分析を行い、活性汚泥のキノンプロファイルを作成する。一般的に1つの菌種・菌属には1つの主要キノン種が存在している。したがって、活性汚泥中のキノン種の存在比はそのまま、各キノン系分類群の分布比を反映するとみなされる。活性汚泥中で炭化水素分解などの重要な働きをするノカルディア科の各属の細菌の存在比を、既知キノン種ならびに本発明の化合物を指標にして見積もることができる。
(2) Bacterial community analysis in activated sludge by quinone profile A chloroform / methanol (2: 1) mixed solvent is added to the sludge suspension and homogenized or sonicated. After centrifugation, the upper aqueous layer is discarded, and the intermediate layer and the lower layer (chloroform layer) are filtered with a filter paper. It is concentrated to dryness and further dissolved with hexane-water (1: 1), and then the hexane layer is separated. The hexane layer is concentrated to dryness, dissolved in a small amount of acetone, and used as a sample for HPLC / PDA / APCI-MS / MS analysis. The composition analysis is performed in the same manner as the composition analysis of the isoprenoid quinone in the above (1) bacterial cells to create a quinone profile of activated sludge. In general, one major quinone species exists in one bacterial species / genus. Therefore, the abundance ratio of quinone species in the activated sludge is considered to reflect the distribution ratio of each quinone taxon as it is. The abundance ratio of bacteria of each genus of Nocardia family that plays an important role such as hydrocarbon decomposition in activated sludge can be estimated using known quinone species and compounds of the present invention as indicators.

以下に本発明を実施例により具体的に説明する。ただし、本発明は実施例によりその技術的範囲が限定されるものではない。   Hereinafter, the present invention will be described specifically by way of examples. However, the technical scope of the present invention is not limited by the examples.

〔実施例1〕 式(I)と(II)の化合物の製造
式(I)と(II)の化合物の生産菌としてHou_blue株を用いた。該菌株を、300mLのW培地にヘキサデカンを1g加えた液体培地を入れた1Lバッフル付き三角フラスコ中で、30℃にて10日間回転振盪(100rpm)培養した。培養中、培地のpHは特に制御しなかった。
[Example 1] Production of compounds of formulas (I) and (II) Hou_blue strain was used as a bacterium producing the compounds of formulas (I) and (II). The strain was cultured for 10 days at 30 ° C. in a conical flask with a 1 L baffle containing a liquid medium obtained by adding 1 g of hexadecane to 300 mL of W medium. During the culture, the pH of the medium was not particularly controlled.

このようにして得られた培養液10Lを遠心分離(6000×g、20分間)し、菌体のみ集めた後、クロロホルム/メタノール(2:1)で抽出した。次に、得られた菌体抽出物をシリカゲルカラムクロマトグラフィーにて精製した。ワコーゲルC200(和光純薬)を担体として用い、移動層として、ヘキサン-酢酸エチル(8:2)(7:3)(1:1)にて準じ溶出、該化合物を含む画分を得た。   10 L of the culture solution thus obtained was centrifuged (6000 × g, 20 minutes), and only the cells were collected, followed by extraction with chloroform / methanol (2: 1). Next, the obtained bacterial cell extract was purified by silica gel column chromatography. Using Wako Gel C200 (Wako Pure Chemical Industries) as a carrier, and elution with hexane-ethyl acetate (8: 2) (7: 3) (1: 1) as a moving layer, a fraction containing the compound was obtained.

次に、それら画分をHPLC(カラム:野村化学Develosil ODS-HG-5(直径4.6mm、長さ250mm)、移動相メタノール-イソプロパノール(7:3、v/v)にて精製し、本発明の式(I)と(II)の化合物をそれぞれ3 mg、1.5mg得た。ここで得た(I)と(II)の化合物は、前記した理化学的性質を示した。   Next, these fractions were purified by HPLC (column: Nomura Chemical Develosil ODS-HG-5 (diameter 4.6 mm, length 250 mm), mobile phase methanol-isopropanol (7: 3, v / v), and the present invention. The compounds of formulas (I) and (II) were obtained in an amount of 3 mg and 1.5 mg, respectively, and the obtained compounds of (I) and (II) exhibited the above-mentioned physicochemical properties.

Claims (6)

下記式(I)で表される化合物。
Figure 2006160699
A compound represented by the following formula (I).
Figure 2006160699
下記式(II)で表される化合物。
Figure 2006160699
A compound represented by the following formula (II).
Figure 2006160699
ノカルディア科に属し、請求項1記載の化合物と請求項2記載の化合物とを生産することを特徴とする微生物。   A microorganism belonging to the family Nocardia and producing the compound according to claim 1 and the compound according to claim 2. 配列番号1記載の塩基配列と97%以上の相同性を示す塩基配列で表される16S rRNA遺伝子を持つ請求項3記載の微生物。   The microorganism according to claim 3, which has a 16S rRNA gene represented by a base sequence having 97% or more homology with the base sequence described in SEQ ID NO: 1. 請求項1記載の化合物又は請求項2記載の化合物を生産する能力を有するノカルディア科微生物を培地に培養し、培養物中に請求項1記載の化合物又は請求項2記載の化合物を生成蓄積させ、該培養物から請求項1記載の化合物又は請求項2記載の化合物を採取することを特徴とする請求項1記載の化合物又は請求項2記載の化合物の製造法。   A Nocardiaceae microorganism having the ability to produce the compound according to claim 1 or the compound according to claim 2 is cultured in a medium, and the compound according to claim 1 or the compound according to claim 2 is produced and accumulated in the culture. The method according to claim 1 or the compound according to claim 2, wherein the compound according to claim 1 or the compound according to claim 2 is collected from the culture. 請求項1記載の化合物又は請求項2記載の化合物を指標とするノカルディア科に属する微生物の分類法。   The classification method of the microorganisms which belong to the Nocardia family which uses the compound of Claim 1 or the compound of Claim 2 as a parameter | index.
JP2004357556A 2004-12-10 2004-12-10 New isoprenoid quinone Pending JP2006160699A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004357556A JP2006160699A (en) 2004-12-10 2004-12-10 New isoprenoid quinone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004357556A JP2006160699A (en) 2004-12-10 2004-12-10 New isoprenoid quinone

Publications (1)

Publication Number Publication Date
JP2006160699A true JP2006160699A (en) 2006-06-22

Family

ID=36663115

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004357556A Pending JP2006160699A (en) 2004-12-10 2004-12-10 New isoprenoid quinone

Country Status (1)

Country Link
JP (1) JP2006160699A (en)

Similar Documents

Publication Publication Date Title
JP2012143238A (en) NOVEL MICROORGANISM,AND METHOD FOR PRODUCING DODECAHYDRO-3a,6,6,9a-TETRAMETHYLNAPHTHO [2,1-b] FURAN INTERMEDIATE USING THE SAME
US4421687A (en) Macbecin derivatives
JP6181972B2 (en) Method for producing aromatic compound
JP3854866B2 (en) Method for producing mycophenolic acid and derivatives thereof
US4421688A (en) Macbecin derivatives
KR960016874B1 (en) Microbial process for the production of trans-4-hydroxy-l-proline
JP5113379B2 (en) Novel microorganism and method for producing dodecahydro-3a, 6,6,9a-tetramethylnaphtho [2,1-b] furan intermediate using the novel microorganism
JP5826406B2 (en) Streptomyces, antitumor compound Spiro-Indymycin AD, production method and use thereof, and antitumor agent and drug containing spiroindimycin
GB2106111A (en) Macbecin derivatives and their production
JP2006160699A (en) New isoprenoid quinone
JP3570741B2 (en) Astaxanthin production method
JP6181971B2 (en) Method for producing aromatic compound
JP4395005B2 (en) Strain producing low degree of polymerization ε-poly-L-lysine and method for producing low degree of polymerization ε-poly-L-lysine using the same
AU655698B2 (en) Process for producing optically active norborneol
JP4598692B2 (en) Novel microorganism and method for producing dodecahydro-3a, 6,6,9a-tetramethylnaphtho [2,1-b] furan intermediate using the novel microorganism
JP4836783B2 (en) Antitumor agent, method for producing antitumor agent, pharmaceutical composition containing antitumor agent, and antitumor agent-producing bacterium
JPH11269175A (en) New ultraviolet-absorbing substance produced by marine bacteria and its production
JP5693052B2 (en) Sugar derivative and method for producing the same
JPH08196288A (en) Production of long-chain fatty acid
EP1431395B1 (en) 7alpha-hydroxypregn-4-en-3-one-20-carbaldehyde, process for producing the same, and process for producing 7alpha,21-dihydroxy-20-methylpregn-4-en-3-one from the same
JP2003070463A (en) Method for decomposing polynuclear aromatic compound by microorganism and treatment agent for the polynuclear aromatic compound
JP4865357B2 (en) New antibiotic
JP5723108B2 (en) Method for producing glucosylglycerate by microorganism
JP2007135445A (en) Method for producing erythroascorbic acid
JPH104991A (en) Novel 3-hydroxybutyric acid oligomer and its production